Research graph
References from 28‐week, randomized, multicenter, open‐label, parallel‐group phase III trial to investigate the efficacy and safety of biphasic insulin aspart 70 thrice‐daily injections vs twice‐daily injections of biphasic insulin aspart 30 in patients with type 2 diabetes. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1002/(sici)1097-4695(199912)41:4<540::aid-neu9>3.0.co;2-p
10.1002/(sici)1097-4695(199912)41:4<540::aid-neu9>3.0.co;2-p · External reference
10.1016/s0140-6736(98)07019-6
10.1016/s0140-6736(98)07019-6 · External reference
10.1016/0168-8227(95)01064-k
10.1016/0168-8227(95)01064-k · External reference
10.1016/s0140-6736(98)12131-1
10.1016/s0140-6736(98)12131-1 · External reference
10.2337/diacare.22.6.920
10.2337/diacare.22.6.920 · External reference
10.1002/dmrr.962
10.1002/dmrr.962 · External reference
10.2174/157016109787354169
10.2174/157016109787354169 · External reference
10.1002/dmrr.938
10.1002/dmrr.938 · External reference
Safety and effectiveness of biphasic insulin aspart 30 (BIAsp 30) in patients with type 2 diabetes (T2D)—IMPROVE Study in Japan (in Japanese)
2009 · External reference
10.1016/j.diabres.2007.08.011
10.1016/j.diabres.2007.08.011 · External reference
10.1111/j.1463-1326.2008.00897.x
10.1111/j.1463-1326.2008.00897.x · External reference
Unresolved reference
2008 · External reference
Comparison between insulin aspart and rapid‐acting human insulin in type 1 diabetes (IDDM) patients treated with basal‐bolus insulin therapy. Phase III clinical trial in Japan (in Japanese)
2001 · External reference
10.1111/j.0954-6820.1965.tb01810.x
10.1111/j.0954-6820.1965.tb01810.x · External reference
Unresolved reference
2008 · External reference
10.1001/archopht.116.7.874
10.1001/archopht.116.7.874 · External reference
Unresolved reference
External reference
